Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q1 EPS of ($0.20), $0.43 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $238 thousand versus the consensus estimate of $56.34 million.

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.